Supernus Pharmaceuticals | SUPN - Capitaux D'Emprunt





Capitaux D'Emprunt Changement Date
Abbott USD 29.64B 19.74B 2026-03
ANI Pharmaceuticals USD 280.15M 5.84M 2026-06
Aurora Cannabis CAD 18.13M 15.07M 2026-03
Bristol-Myers Squibb USD 42.09B 59M 2026-06
Canopy Growth CAD 217.12M 7.87M 2026-03
Cara Therapeutics USD 0 0 2025-03
Eisai JPY 184.6B 49.83B 2026-06
Eli Lilly USD 47.86B 8.49B 2026-06
Novo Nordisk DKK 121.79B 2.62B 2026-06
Pacira USD 363.12M 4.53M 2026-06
Perrigo USD 3.28B 337.7M 2026-06
Pfizer USD 60.5B 70M 2026-06
Supernus Pharmaceuticals USD 400.38M 21.13M 2022-03
United Therapeutics USD 100M 100M 2024-06
Xeris Pharmaceuticals USD 188.81M 32.42M 2026-06